126 related articles for article (PubMed ID: 210151)
21. Effect of polymyxin B on kappa phage adsorption on Serratia marcescens HY.
Patel KA; Patel IR; Mehta AM; Dave PJ
Indian J Exp Biol; 1980 Nov; 18(11):1353-4. PubMed ID: 6260637
[No Abstract] [Full Text] [Related]
22. Outer membrane proteins of polymyxin resistant Pseudomonas aeruginosa: effect of magnesium depletion.
Shand GH; Anwar H; Brown MR
J Antimicrob Chemother; 1988 Dec; 22(6):811-21. PubMed ID: 2854118
[TBL] [Abstract][Full Text] [Related]
23. Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections.
Ostenson RC; Fields BT; Nolan CM
Antimicrob Agents Chemother; 1977 Dec; 12(6):655-9. PubMed ID: 201214
[TBL] [Abstract][Full Text] [Related]
24. Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism.
Gilleland HE; Farley LB
Can J Microbiol; 1982 Jul; 28(7):830-40. PubMed ID: 6293694
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of polymyxin B on prodigiosin biosynthesis in Serratia marcescens.
Tsang JC; Sheung X
J Antibiot (Tokyo); 1980 Apr; 33(4):455-7. PubMed ID: 6251020
[No Abstract] [Full Text] [Related]
26. Evidence for two distinct mechanisms of resistance to polymyxin B in Pseudomonas aeruginosa.
Moore RA; Chan L; Hancock RE
Antimicrob Agents Chemother; 1984 Oct; 26(4):539-45. PubMed ID: 6097168
[TBL] [Abstract][Full Text] [Related]
27. Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens.
Traub WH; Kleber I
Chemotherapy; 1975; 21(3-4):189-204. PubMed ID: 169108
[TBL] [Abstract][Full Text] [Related]
28. Inverse relationship between the flagella formation and prodigiosin synthesis in Serratia marcescens.
Kobayashi N; Ichikawa Y
Microbiol Immunol; 1990; 34(4):347-54. PubMed ID: 2113984
[TBL] [Abstract][Full Text] [Related]
29. Effects of carbon sources on chemical composition of cell envelopes of Pseudomonas aeruginosa in association with polymyxin resistance.
Gilleland HE; Conrad RS
Antimicrob Agents Chemother; 1980 Apr; 17(4):623-8. PubMed ID: 6249193
[TBL] [Abstract][Full Text] [Related]
30. Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium.
Peterson AA; Fesik SW; McGroarty EJ
Antimicrob Agents Chemother; 1987 Feb; 31(2):230-7. PubMed ID: 3032093
[TBL] [Abstract][Full Text] [Related]
31. Different mechanisms of resistance to latamoxef (moxalactam) in Serratia marcescens.
Gutmann L; Chabbert YA
J Antimicrob Chemother; 1984 Jan; 13(1):15-22. PubMed ID: 6365875
[TBL] [Abstract][Full Text] [Related]
32. Pleiotropic consequences of mutations towards antibiotic-hypersensitivity in Serratia marcescens.
Winkler U; Heller KB; Folle B
Arch Microbiol; 1978 Mar; 116(3):259-68. PubMed ID: 348145
[TBL] [Abstract][Full Text] [Related]
33. Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts.
Freer E; Moreno E; Moriyón I; Pizarro-Cerdá J; Weintraub A; Gorvel JP
J Bacteriol; 1996 Oct; 178(20):5867-76. PubMed ID: 8830680
[TBL] [Abstract][Full Text] [Related]
34. Dose-dependent reduction of lipopolysaccharide pyrogenicity by polymyxin B.
Warner SJ; Mitchell D; Savage N; McClain E
Biochem Pharmacol; 1985 Nov; 34(22):3995-8. PubMed ID: 2998395
[TBL] [Abstract][Full Text] [Related]
35. In vitro additive effect of polymxin B and rifampin against Serratia marcesen.
Traub WH; Kleber I
Antimicrob Agents Chemother; 1975 Jun; 7(6):874-6. PubMed ID: 168807
[TBL] [Abstract][Full Text] [Related]
36. Effect of polymyxins on the lipopolysaccharide-defective mutants of Proteus mirabilis.
Kaca W; Radziejewska-Lebrecht J; Bhat UR
Microbios; 1990; 61(246):23-32. PubMed ID: 2156134
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic polymyxin arranges lipopolysaccharide into crystalline structures to solidify the bacterial membrane.
Manioglu S; Modaresi SM; Ritzmann N; Thoma J; Overall SA; Harms A; Upert G; Luther A; Barnes AB; Obrecht D; Müller DJ; Hiller S
Nat Commun; 2022 Oct; 13(1):6195. PubMed ID: 36271003
[TBL] [Abstract][Full Text] [Related]
38. Pyocin-resistant lipopolysaccharide mutans of Neisseria gonorrhoeae: alterations in sensitivity to normal human serum and polymyxin B.
Guymon LF; Esser M; Shafer WM
Infect Immun; 1982 May; 36(2):541-7. PubMed ID: 6282751
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of polymyxin B-mediated lysis of lipopolysaccharide-treated erythrocytes.
Carr C; Morrison DC
Infect Immun; 1985 Jul; 49(1):84-9. PubMed ID: 2989182
[TBL] [Abstract][Full Text] [Related]
40. Alteration of susceptibility to EDTA, polymyxin B and gentamicin in Pseudomonas aeruginosa by divalent cation regulation of outer membrane protein H1.
Nicas TI; Hancock RE
J Gen Microbiol; 1983 Feb; 129(2):509-17. PubMed ID: 6302204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
